Pulmonary infections (PIs) are contributing as a significant cause of mortality across the
world. The clinical applications of a variety of therapeutics approved for PIs have been …

Nontuberculous mycobacterial (NTM) pulmonary disease is a chronic respiratory infection
associated with declining lung function, radiological deterioration and significantly increased …

As a symbol of the defense mechanisms that bacteria have evolved over time, the genes that
make bacteria resist antibiotics are overwhelmingly present in the environment. Currently …

Multidrug resistance (MDR) among Pseudomonas aeruginosa (PSA) isolates presents a
significant clinical challenge and can substantially complicate the approach to selection of …

Cystic fibrosis is a genetic disease that results in progressive multi-organ manifestations with
predominance in the respiratory and gastrointestinal systems. The significant morbidity and …

In this Series paper, we review the current evidence for the use of high-flow oxygen therapy,
inhaled gases, and aerosols in the care of critically ill patients. The available evidence …

Understanding the fundamentals of surface transport on thin viscous films has important
application in pulmonary drug delivery. The human lung contains a large-area interface …

To this day, any photosensitizers for the photodynamic treatment of pulmonary illnesses
have been administered intravenously. There is, however, an intrinsic difficulty in reaching …

Despite advancements in therapy, pneumonia remains the leading cause of death due to
infectious diseases. Novel treatment strategies are desperately needed to optimize the …

The inhaled route is critical for the administration of drugs to treat patients suffering from
COPD, but there is still an unmet need for new and innovative inhalers to address some …